Blue Bell Private Wealth Management’s Editas Medicine EDIT Stock Holding History

Blue Bell Private Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-139	Closed	-$177	–	732
2024 Q4	$177	Hold	139	–	–	﹤0.01%	666
2024 Q3	$474	Hold	139	–	–	﹤0.01%	671
2024 Q2	$649	Hold	139	–	–	﹤0.01%	684
2024 Q1	$1.03K	Sell	139 -40	-22%	-$332	﹤0.01%	673
2023 Q4	$1.81K	Hold	179	–	–	﹤0.01%	631
2023 Q3	$1.4K	Hold	179	–	–	﹤0.01%	599
2023 Q2	$1.47K	Hold	179	–	–	﹤0.01%	607
2023 Q1	$1.3K	Hold	179	–	–	﹤0.01%	591
2022 Q4	$1.59K	Hold	179	–	–	﹤0.01%	590
2022 Q3	$2K	Sell	179 -30	-14%	-$467	﹤0.01%	591
2022 Q2	$2K	Hold	209	–	–	﹤0.01%	632
2022 Q1	$4K	Hold	209	–	–	﹤0.01%	584
2021 Q4	$6K	Buy	+209	New	+$7.19K	﹤0.01%	492

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Blue Bell Private Wealth Management's EDIT Position: Q1 2025 in Review

Blue Bell Private Wealth Management sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 139 shares — an estimated $177 sold.

Blue Bell Private Wealth Management first reported a position in EDIT in Q4 2021 and held it in 13 quarters. The position peaked at $6K in Q4 2021. 195 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

Blue Bell Private Wealth Management reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
Blue Bell Private Wealth Management sold 139 Editas Medicine shares in Q1 2025, an estimated $177.
Blue Bell Private Wealth Management first reported a position in Editas Medicine in Q4 2021 and held it in 13 quarters.
Blue Bell Private Wealth Management's Editas Medicine position peaked at $6K in Q4 2021.
195 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Blue Bell Private Wealth Management's 13F filing for Q1 2025, filed 5 May 2025.